Short-Term Trade Opportunity! I took a punt. Phase III top line clinical trial data (for schizophrenia) expected before year-end. Reviva Pharmaceuticals (RVPH, NASDAQ) $1.65 per share…

Where Gold may have to land in 2025…

Get ready for something REALLY BIG…

Canada’s embarrassing economic under-performance vs. the U.S., and updates on several hot market plays…

How the Venture is lining up for a big finish to 2024…

Gold begins the new week in rally mode…

An extraordinary period rapidly approaches for the Venture…

Bitcoin tops $90,000 for the first time and Trump moves at lightning speed to reshape America for decades to come…

New record high for Bitcoin, and updates on 3 hot stocks…

Exit mobile version